Kefloridina Forte

Cefalexin, the active ingredient in Kefloridina Forte, is a first‑generation cephalosporin presented as an oral dosage form for oral use. It treats bacterial infections of the skin, respiratory tract, urinary system, and bone or joint in both adults and children as prescribed. GNH USA supplies Kefloridina Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Cefalexin, the component of Kefloridina Forte, acts on a broad range of Gram‑positive and some Gram‑negative bacteria, making it suitable for several infection types.

Skin and soft tissue infections: effective against common pathogens, helping resolve cellulitis and wound infections. Respiratory tract infections: treats acute bronchitis, sinusitis and pneumonia caused by susceptible organisms. Urinary tract infections: eradicates Escherichia coli and other uropathogens in uncomplicated UTIs. Bone and joint infections: used for osteomyelitis and septic arthritis when indicated.

Adverse reactions may occur with any antibiotic and should be monitored.

Common Side Effects: - Nausea or vomiting - Diarrhea or loose stools - Abdominal pain or discomfort - Rash or mild skin irritation - Headache - Mild elevation of liver enzymes

Serious or Rare Side Effects: - Anaphylactic or severe allergic reactions - Clostridioides difficile‑associated colitis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hematologic abnormalities such as neutropenia - Significant liver injury or hepatitis - Acute kidney injury in susceptible patients

Before prescribing Kefloridina Forte, clinicians should evaluate patient history and laboratory values. - Allergy assessment: avoid in patients with known cephalosporin or severe penicillin allergy. - Renal function: adjust dose in patients with impaired kidney function. - Hepatic function: monitor liver enzymes in patients with existing liver disease. - Pediatric use: dose is weight‑based and determined by the prescriber. - Pregnancy and lactation: use only if clearly needed after risk‑benefit analysis. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Cefalexin may interact with several medicines, requiring caution.

Major Interactions (Avoid): - Probenecid: can increase cefalexin plasma concentrations, raising toxicity risk. - Warfarin: may enhance anticoagulant effect, necessitating INR monitoring. - Oral contraceptives: may reduce efficacy, consider alternative contraception.

Moderate Interactions (Monitor Closely): - Aminoglycosides: combined nephrotoxic potential, monitor renal function. - Loop diuretics: may affect renal clearance, adjust dosing if needed. - Other antibiotics (e.g., bacteriostatic agents): possible antagonism, assess clinical relevance.